Research Paper Volume 16, Issue 3 pp 2320—2339
Comprehensive analysis of ALG3 in pan-cancer and validation of ALG3 as an onco-immunological biomarker in breast cancer
Figure 1. Expression levels and prognostic analysis of ALG3 in pan-cancer. (A) ALG3 expression difference in across tumors integrating data of normal tissues in GTEx database and data of TCGA tumor tissues, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. (B) Forest plot of the relationship between ALG3 expression and overall survival time. (C) Forest plot of the relationship between ALG3 expression and disease-free survival time.